North America Ocular Implants Market Size, Share, and COVID-19 Impact Analysis, By Product (Intraocular Lens, Corneal Implants, Orbital Implants, Glaucoma Implants, Ocular Prosthesis, and Others), By Application (Glaucoma Surgery, Oculoplasty, Drug Delivery, Age-related Macular Degeneration, and Aesthetic Purpose), and North America, Ocular Implants Market Insights, Industry Trend, Forecasts to 2035

North America Ocular Implants Market Insights Forecasts to 2035

• The North America Ocular Implants Market Size Was Estimated at USD 5.72 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of Around 4.84% from 2025 to 2035
• The North America Ocular Implants Market Size is Expected to Reach USD 9.62 Billion by 2035

According to a research report published by Spherical Insights & Consulting, the North America Ocular Implants market is anticipated to reach USD 9.62 billion by 2035, growing at a CAGR of 4.84% from 2025 to 2035. Technology developments, the growing need for vision correction, the aging population, better healthcare facilities, and the expanding use of cutting-edge ophthalmic therapies are some of the opportunities offered by the North America ocular implants market.

Market Overview

The manufacturing, development, and usage of ocular implants, such as intraocular lenses (IOLs), corneal implants, glaucoma implants, and ocular prosthesis, are the main focuses of the North America ocular implants market. These implants are utilized in the treatment of age-related macular degeneration (AMD), oculoplasty, glaucoma surgery, and medication delivery. Numerous factors, including the aging of the world's population, the increasing prevalence of ocular illnesses, improvements in implant technology, greater awareness of corrective eye procedures, and rising healthcare costs, are contributing to the growth in the market. Technological developments, the rise in ocular illnesses, and the growing need for vision correction products are the main factors driving the growth of North America ocular implants market. Increased adoption of vision correction operations, technical improvements, and the rising prevalence of ocular ailments, such as glaucoma, scleritis, and Age-Related Macular Degeneration (AMD), are the main factors propelling the North America ocular implants market.  

Report Coverage

This research report categorizes the market for North America ocular implants market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the North America ocular implants market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the North America ocular implants market. 

Driving Factors

The need for ocular implants is anticipated to rise due to the rising incidence of corneal illness, driving the North America ocular implants market. Increased use of virtual gadgets, a growing number of elderly and diabetic people, and the rising prevalence of eye conditions such as age-related macular degeneration, glaucoma, corneal disease, and scleritis are some of the factors propelling the North America ocular implants market. The market is expanding as a result of an increase in diabetic retinopathy cases. The market for ocular implants is expanding due in large part to the rising incidence of eye disorders. The market for ocular implants is anticipated to develop as more and more products are introduced.

Restraining Factors

The strict regulatory approvals and recent product recalls are the main factors restricting the growth of the North America ocular implant market.

Market Segmentation

The North America ocular implants market share is classified into product and application.

• The glaucoma implants segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

The North America ocular implants market is segmented by product into intraocular lens, corneal implants, orbital implants, glaucoma implants, ocular prosthesis, and others. Among these, the glaucoma implants segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The growing prevalence of glaucoma, one of the main causes of blindness worldwide, is responsible for the glaucoma implants market. The disease mainly affects people over 60, a group that is increasing as the world's population ages.  

• The glaucoma surgery segment held a largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The North America ocular implants market is segmented by application into glaucoma surgery, oculoplasty, drug delivery, age-related macular degeneration, and aesthetic purpose. Among these, the glaucoma surgery segment held a largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The need for efficient surgical treatments, including trabeculectomy, tube shunts, and minimally invasive glaucoma surgeries (MIGS), which provide safer and less invasive alternatives to conventional operations, is the reason for the rise in glaucoma surgery.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the North America ocular implants market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Alcon Inc
• Staar Surgical Co
• Morcher
• Glaukos Corp
• Bausch & Lomb Corp
• Johnson & Johnson
• Carl Zeiss Meditec AG
• Others

Recent Developments

• In September 2024, Johnson & Johnson, a leader in eye health, announced that it can be increasing the use of TECNIS Odyssey, its most recent development in presbyopia-correcting intraocular lenses (PC-IOLs), in the United States.  

Key Target Audience 

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at North America, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the North America ocular implants market based on the below-mentioned segments:

North America Ocular Implants Market, By Product

• Intraocular Lens
• Corneal Implants
• Orbital Implants
• Glaucoma Implants
• Ocular Prosthesis
• Others

North America Ocular Implants Market, By Application

• Cardiac Aneurysm
• Endovascular Stent Graft
• Vascular Graft
• Kidney Failure
• Vascular Occlusion
• Coronary Artery Disease